The authors report the incidence, risk factors, and clinical significance of acute kidney injury (AKI) associated with everolimus treatment in patients with cancer. This study suggests that AKI is a common adverse effect of everolimus treatment, especially in subjects with impaired renal function.

READ FULL ARTICLE Curated publisher From Mdlinx